/
/
Ein Hochdurchsatz-Assay unterstützte Wirksamkeit von Medikamenten gegen Makrophagen agierten zur Bewertung<em> Mycobacterium tuberculosis</em
A subscription to JoVE is required to view this content. Sign in or start your free trial.
7,647 Views
•
10:29 min
•
March 24, 2017
DOI:
Summary
Automatically generated
New models and assays that would improve the early drug development process for next-generation anti-tuberculosis drugs are highly desirable. Here, we describe a quick, inexpensive, and BSL-2 compatible assay to evaluate drug efficacy against Mycobacterium tuberculosis that can be easily adapted for high-throughput screening.
Read Article
Cite this Article
Schaaf, K., Smith, S. R., Hayley, V., Kutsch, O., Sun, J. A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis. J. Vis. Exp. (121), e55453, doi:10.3791/55453 (2017).
Copy